Skip to main content
. 2020 Sep 9;10:543562. doi: 10.3389/fonc.2020.543562

FIGURE 2.

FIGURE 2

VEGFR2 inhibition decreases osteosarcoma cell invasion and migration. (A) Apatinib did not obviously influence KHOS and U2OS cell viability at concentrations of 0.5, 1.0, and 1.5 μM. Proliferation of these two cell lines in response to apatinib treatment was confirmed via cell colony formation analysis. (B) Both shNC and shVEGFR2 lentiviruses were transferred into KHOS and U2OS cells, following estimation of VEGFR2 expression via WB and RT-PCR. (C,D) Both apatinib treatment and VEGFR2 knockdown significantly attenuated the KHOS and U2OS cell migratory and invasive abilities, as demonstrated by a Transwell assay. (Magnification at 100×), (mean ± S.D., n = 3), ***p < 0.001.